10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology ofAspergillusspp. infection in lung transplantation

Maddalena Peghin; Víctor Monforte; Maria-Teresa Martin-Gomez; Isabel Ruiz-Camps; Cristina Berastegui; Berta Saez; Jordi Riera; Piedad Ussetti; Juan Solé; Joan Gavaldà; Antonio Roman

doi:10.1111/tri.12679

journal article Oct 12, 2015

10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology ofAspergillusspp. infection in lung transplantation

Maddalena Peghin Víctor Monforte Maria-Teresa Martin-Gomez Isabel Ruiz-Camps Cristina Berastegui Berta Saez Jordi Riera

Piedad Ussetti Juan Solé Joan Gavaldà Antonio Roman

Transplant International Vol. 29 No. 1 pp. 51-62 · Frontiers Media SA

View at Publisher Save 10.1111/tri.12679

Topics

No keywords indexed for this article. Browse by subject →

References

36

[1]

Pappas "Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)" Clin Infect Dis (2010) 10.1086/651262

[2]

Neofytos "Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients" Transpl Infect Dis (2010) 10.1111/j.1399-3062.2010.00492.x

[3]

Bhaskaran "Anti-aspergillus prophylaxis in lung transplantation: a systematic review and meta-analysis" Curr Infect Dis Rep (2013) 10.1007/s11908-013-0380-y

[4]

Monforte "Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors" J Heart Lung Transplant (2001) 10.1016/s1053-2498(01)00364-3

[5]

Lionakis "Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli" Diagn Microbiol Infect Dis (2005) 10.1016/j.diagmicrobio.2005.01.001

[6]

Monforte "Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation" J Heart Lung Transplant (2010) 10.1016/j.healun.2009.11.603

[7]

Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety

Víctor Monforte, Piedad Ussetti, Rosa López et al.

The Journal of Heart and Lung Transplantation 2009 10.1016/j.healun.2008.11.004

[8]

Drew "Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients" Transplantation (2004) 10.1097/01.tp.0000101516.08327.a9

[9]

Lowry "Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study" Transpl Infect Dis (2007) 10.1111/j.1399-3062.2007.00209.x

[10]

Monforte "Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant" J Heart Lung Transplant (2013) 10.1016/j.healun.2012.11.013

[11]

De Pauw "Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group" Clin Infect Dis (2008) 10.1086/588660

[12]

Husain "A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients" J Heart Lung Transplant (2011) 10.1016/j.healun.2011.01.701

[13]

Valentine "Infections in lung allograft recipients: ganciclovir era" J Heart Lung Transplant (2008) 10.1016/j.healun.2007.12.013

[14]

Singh "Aspergillosis in solid organ transplantation" Am J Transplant (2013) 10.1111/ajt.12115

[15]

Gavalda "Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study" Clin Infect Dis (2005) 10.1086/430602

[16]

Herbrecht "Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis" N Engl J Med (2002) 10.1056/nejmoa020191

[17]

Husain "Voriconazole prophylaxis in lung transplant recipients" Am J Transplant (2006) 10.1111/j.1600-6143.2006.01548.x

[18]

Eriksson "Control of early Aspergillus mortality after lung transplantation: outcome and risk factors" Transpl Proc (2010) 10.1016/j.transproceed.2010.09.116

[19]

Hayes "Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole" Exp Clin Transplant (2011)

[20]

Cadena "Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness" Am J Transplant (2009) 10.1111/j.1600-6143.2009.02734.x

[21]

Mitsani "Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity" Antimicrob Agents Chemother (2012) 10.1128/aac.05219-11

[22]

Singh "Late-onset invasive aspergillosis in organ transplant recipients in the current era" Med Mycol (2006) 10.1080/13693780600684494

[23]

Neoh "Antifungal prophylaxis in lung transplantation-a world-wide survey" Am J Transplant (2011) 10.1111/j.1600-6143.2010.03375.x

[24]

Alastruey-Izquierdo "Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study)" Antimicrob Agents Chemother (2013) 10.1128/aac.00383-13

[25]

Garcia-Vidal "Environmental variables associated with an increased risk of invasive aspergillosis" Clin Microbiol Infect (2014) 10.1111/1469-0691.12650

[26]

Alastruey-Izquierdo "Comparison of dimethyl sulfoxide and water as solvents for echinocandin susceptibility testing by the EUCAST methodology" J Clin Microbiol (2012) 10.1128/jcm.00791-12

[27]

Torres "Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus" Diagn Microbiol Infect Dis (2003) 10.1016/s0732-8893(03)00013-0

[28]

Caston "Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi" Chest (2007) 10.1378/chest.06-0767

[29]

Cahill "Aspergillus airway colonization and invasive disease after lung transplantation" Chest (1997) 10.1378/chest.112.5.1160

[30]

Sole "Aspergillus infections in lung transplant recipients: risk factors and outcome" Clin Microbiol Infect (2005) 10.1111/j.1469-0691.2005.01128.x

[31]

Monforte "Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients" Transplantation (2003) 10.1097/01.tp.0000054233.60100.7a

[32]

Weigt "Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome" Am J Transplant (2009) 10.1111/j.1600-6143.2009.02635.x

[33]

Weigt "Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study" Am J Transplant (2013) 10.1111/ajt.12131

[34]

Westney "Aspergillus infection in single and double lung transplant recipients" Transplantation (1996) 10.1097/00007890-199603270-00013

[35]

Paugam "Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France" Med Mycol (2010) 10.3109/13693786.2010.503665

[36]

Muller "Aspergillus fumigatus biofilms in the clinical setting" Med Mycol (2011) 10.3109/13693786.2010.502190

Metrics

76

Citations

36

References

Details

Published: Oct 12, 2015
Vol/Issue: 29(1)
Pages: 51-62
License: View

Authors

M

Maddalena Peghin

Department of Infectious Diseases; Hospital Universitari de la Vall d'Hebron; Barcelona Spain; Department of Medicine; Universitat Autònoma de Barcelona; Barcelona Spain

V

Víctor Monforte

Department of Pulmonology and Lung Transplant Unit; Hospital Universitari de la Vall d'Hebron; Barcelona Spain; Ciber Enfermedades Respiratorias (CIBERES); Instituto de Salud Carlos III; Madrid Spain

M

Maria-Teresa Martin-Gomez

Department of Microbiology; Hospital Universitari de la Vall d'Hebron; Barcelona Spain

I

Isabel Ruiz-Camps

Department of Infectious Diseases; Hospital Universitari de la Vall d'Hebron; Barcelona Spain; Department of Medicine; Universitat Autònoma de Barcelona; Barcelona Spain

C

Cristina Berastegui

Department of Pulmonology and Lung Transplant Unit; Hospital Universitari de la Vall d'Hebron; Barcelona Spain; Ciber Enfermedades Respiratorias (CIBERES); Instituto de Salud Carlos III; Madrid Spain

B

Berta Saez

Department of Pulmonology and Lung Transplant Unit; Hospital Universitari de la Vall d'Hebron; Barcelona Spain; Ciber Enfermedades Respiratorias (CIBERES); Instituto de Salud Carlos III; Madrid Spain

J

Jordi Riera

Department of Intensive Care Unit; Hospital Universitari de la Vall d'Hebron; Barcelona Spain

P

Piedad Ussetti

Department of Pulmonology and Lung Transplant Unit; Hospital Puerta del Hierro; Madrid Spain

J

Juan Solé

Department of Thoracic Surgery; Hospital Universitari de la Vall d'Hebron; Barcelona Spain

J

Joan Gavaldà

Department of Infectious Diseases; Hospital Universitari de la Vall d'Hebron; Barcelona Spain; Department of Medicine; Universitat Autònoma de Barcelona; Barcelona Spain

A

Antonio Roman

Department of Pulmonology and Lung Transplant Unit; Hospital Universitari de la Vall d'Hebron; Barcelona Spain; Ciber Enfermedades Respiratorias (CIBERES); Instituto de Salud Carlos III; Madrid Spain

Cite This Article

Maddalena Peghin, Víctor Monforte, Maria-Teresa Martin-Gomez, et al. (2015). 10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology ofAspergillusspp. infection in lung transplantation. Transplant International, 29(1), 51-62. https://doi.org/10.1111/tri.12679

10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology ofAspergillusspp. infection in lung transplantation

You May Also Like